1. Frequency of inhibitor development in haemophiliacs treated with low purity factor VIII;Addiego;Lancet,1993
2. Molecular etiology of factor VIII deficiency in hemophilia A;Antonarakis;Human Mutation,1995
3. Kogenate: a recombinant technology derived human antihemophilic factor (FVIII) concentrate;Arkin,1995
4. Deletion of the B-domain in a recombinant factor VIII (r-VIII SQ) does not affect the main kinetic properties—three pharmacokinetic studies in 36 patients with severe hemophilia A;Berntorp;Thrombosis and Haemostasis,1995
5. The manufacturing of recombinant factor VIII, Kogenate;Boedeker;Transfusion Medicine Reviews,1992